课题基金 / 基金详情

the elucidation of recurrence and malignant alteration mechanism of inverted papilloma

the elucidation of recurrence and malignant alteration mechanism of inverted papilloma
内翻性乳头状瘤复发及恶变机制的阐明
批准号:
22791614
负责人:
HASEGAWA Masahiro
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010-04-01 至 2014-03-31

项目摘要

项目成果

HASEGAWA Masahiro的其他基金

相关文献

中文摘要
翻译
鼻窦内翻性乳头状瘤是一种良性肿瘤,但临床上存在两个问题。IP易复发(术后复发率20%),有恶性转化的可能(约10%)。本研究的最终目的是评估手术前复发和恶性转化的可能性。患者血清中鳞状细胞癌抗原(SCCA)的检测对诊断IP的存在和复发及病理检查有重要意义。鼻窦炎中SCCA2/1 mRNA的表达比例与鼻窦炎相当,而鼻旁癌中SCCA2/1的表达比例明显高于鼻旁癌。组织中SCCA2/1比值提示IP可能发生恶性转化。由于HPV在IP中的存在率为46.1%,HPV具有制造IP的潜力,HPV的整合也会导致IP的恶性转化。
英文摘要
Although sinonasal inverted papilloma (IP) is one of the benign tumor, there are two clinical problems about it. IP is easy to recur (the rate of recurrence after operation: 20%), and has a potential of malignant transformation (approximately 10%). The final goal of this study is to evaluate the potential of recurrence and malignant transformation before surgery. The squamous cell carcinoma antigen (SCCA) in IP patient's serum was useful to diagnosis of IP presence and recurrence as well as pathologic examination. The SCCA2/1 ratio of mRNA expression in IP was equivalent to those in sinusitis, while paranasal cancer demonstrated the significantly higher SCCA2/1 ratio. The SCCA2/1 ratio in tissue may indicate the possible malignant transformation of IP. Since the HPV presence rate in IP was 46.1%, HPV has a potential of making IP and integration of HPV also causes the malignant transformation of IP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
鼻副鼻腔内反性乳頭腫の診断と治療扁平上皮癌抗原とヒト乳頭腫ウイルス感染を中心に
鼻窦内翻乳头状瘤的诊治,重点关注鳞状细胞癌抗原和人乳头瘤病毒感染
DOI: --
发表时间: 2012
期刊: 耳鼻臨床
影响因子: --
作者: [鈴木幹男, 長谷川昌宏]
通讯作者: 長谷川昌宏
篩骨蜂巣―その不思議なもの―Onodi蜂巣
筛状蜂窝 - 神秘的东西 - Onodi 蜂窝
DOI: --
发表时间: 2013
期刊: JOHNS
影响因子: --
作者: [真栄田裕行, 鈴木幹男, 兵頭政光, 長谷川昌宏,真栄田裕行,鈴木幹男]
通讯作者: 長谷川昌宏,真栄田裕行,鈴木幹男
PET検査、HPV検査からみた中咽頭癌に対する計画的頸部郭清術
基于 PET 和 HPV 检测的口咽癌计划颈清扫术
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [長谷川昌宏, 他]
通讯作者:
DOI: 10.1002/hed.23034
发表时间: 2013-06-01
期刊: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
影响因子: 2.9
作者: [Deng, Zeyi, Hasegawa, Masahiro, Suzuki, Mikio]
通讯作者: Suzuki, Mikio
15
    Applied treatment for cartilage using tenascin C domain (TNIIIA2)
    • 批准号:
      17K11003
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      HASEGAWA Masahiro
    • 依托单位:
    Mechanism of articular cartilage repair and prevention of cartilage degeneration with tenascin C and application for treatment
    • 批准号:
      25462367
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      HASEGAWA Masahiro
    • 依托单位:
    Evolutinary diversification of the flower tube and ecological speciation in Melampyrum
    • 批准号:
      24770085
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      HASEGAWA Masahiro
    • 依托单位:
    Development of a new recycling process of the aggregate recovered from waste concrete
    • 批准号:
      23656484
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      HASEGAWA Masahiro
    • 依托单位: